Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Etacrynic-acid | hsa00040 | Pentose and glucuronate interconversions | 2.33E-04 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Etacrynic-acid | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 3.56E-02 | 1 | Q9Y2C2 | UST | More | | Etacrynic-acid | hsa00561 | Glycerolipid metabolism | 2.62E-02 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Etacrynic-acid | hsa00790 | Folate biosynthesis | 2.02E-02 | 1 | P15121 | AKR1B1 | More | | Etacrynic-acid | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 2.97E-03 | 3 | P78417, P09211, P11712 | GSTO1, GSTP1, CYP2C9 | More | | Etacrynic-acid | hsa00982 | Drug metabolism - cytochrome P450 | 3.10E-02 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Etacrynic-acid | hsa00983 | Drug metabolism - other enzymes | 1.63E-02 | 2 | P20839, Q16772 | IMPDH1, GSTA3 | More | | Etacrynic-acid | hsa01100 | Metabolic pathways | 2.59E-02 | 11 | P35790, Q16772, P30041, P20839, O94777, P15121, O95861, P14550, Q9UHK6, Q86VZ5, Q9NVH6 | CHKA, GSTA3, PRDX6, IMPDH1, DPM2, AKR1B1, BPNT1, AKR1A1, AMACR, SGMS1, TMLHE | More | | Etacrynic-acid | hsa03010 | Ribosome | 2.25E-04 | 5 | P40429, Q07020, P27635, P05386, P62249 | RPL13A, RPL18, RPL10, RPLP1, RPS16 | More | | Etacrynic-acid | hsa03013 | RNA transport | 3.63E-02 | 7 | P52298, Q09161, O14893, Q7Z3B4, Q14152, O75822, P78345 | NCBP2, NCBP1, GEMIN2, NUP54, EIF3A, EIF3J, RPP38 | More | | Etacrynic-acid | hsa03040 | Spliceosome | 1.27E-02 | 6 | O43143, P08579, Q13595, Q07955, P84103, P11142 | DHX15, SNRPB2, TRA2A, SFRS1, SFRS3, HSPA8 | More | | Etacrynic-acid | hsa04014 | Ras signaling pathway | 4.12E-02 | 5 | P20827, P49767, Q14644, P0DP23, P63218 | EFNA1, VEGFC, RASA3, CALM1, GNG5 | More | | Etacrynic-acid | hsa04020 | Calcium signaling pathway | 3.36E-03 | 6 | Q16566, P30679, O15399, P0DP23, P23634, P49767 | CAMK4, GNA15, GRIN2D, CALM1, ATP2B4, VEGFC | More | | Etacrynic-acid | hsa04064 | NF-kappa B signaling pathway | 1.25E-03 | 9 | P10415, Q13489, P51617, O00463, Q13546, Q9UDY8, Q13077, Q16548, Q8WV28 | BCL2, BIRC3, IRAK1, TRAF5, RIPK1, MALT1, TRAF1, BCL2A1, BLNK | More | | Etacrynic-acid | hsa04110 | Cell cycle | 4.67E-03 | 5 | Q09472, P24522, P49918, P42773, P01106 | EP300, GADD45A, CDKN1C, CDKN2C, MYC | More | | Etacrynic-acid | hsa04142 | Lysosome | 1.96E-02 | 3 | Q9UBR2, P34059, P17900 | CTSZ, GALNS, GM2A | More | | Etacrynic-acid | hsa04210 | Apoptosis | 4.30E-02 | 7 | P10415, Q13489, Q13546, Q16548, Q13077, Q9UBR2, Q14643 | BCL2, BIRC3, RIPK1, BCL2A1, TRAF1, CTSZ, ITPR1 | More | | Etacrynic-acid | hsa04371 | Apelin signaling pathway | 4.16E-02 | 4 | P63218, Q13485, Q16566, P0DP23 | GNG5, SMAD4, CAMK4, CALM1 | More | | Etacrynic-acid | hsa04610 | Complement and coagulation cascades | 4.48E-02 | 3 | P01042, P09871, P11215 | KNG1, C1S, ITGAM | More | | Etacrynic-acid | hsa04630 | JAK-STAT signaling pathway | 4.43E-02 | 3 | P01106, Q09472, P16871 | MYC, EP300, IL7R | More | | Etacrynic-acid | hsa04640 | Hematopoietic cell lineage | 8.35E-03 | 4 | P20023, P09693, P01730, P16871 | CR2, CD3G, CD4, IL7R | More | | Etacrynic-acid | hsa04660 | T cell receptor signaling pathway | 4.41E-02 | 6 | Q9UDY8, P10747, O95267, Q08881, P09693, P10966 | MALT1, CD28, RASGRP1, ITK, CD3G, CD8B | More | | Etacrynic-acid | hsa04720 | Long-term potentiation | 1.79E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Etacrynic-acid | hsa04724 | Glutamatergic synapse | 4.48E-02 | 3 | O15399, P63218, Q9NSB8 | GRIN2D, GNG5, HOMER2 | More | | Etacrynic-acid | hsa04922 | Glucagon signaling pathway | 4.91E-02 | 4 | P06737, Q12778, Q14643, P07195 | PYGL, FOXO1, ITPR1, LDHB | More | | Etacrynic-acid | hsa04925 | Aldosterone synthesis and secretion | 3.44E-02 | 3 | P0DP23, Q16566, P23634 | CALM1, CAMK4, ATP2B4 | More | | Etacrynic-acid | hsa05034 | Alcoholism | 4.05E-04 | 9 | O15399, P07101, Q16566, P0DP23, P63218, P62807, P33778, O60814, P68431 | GRIN2D, TH, CAMK4, CALM1, GNG5, HIST1H2BC, H2BC3, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Etacrynic-acid | hsa05132 | Salmonella infection | 6.27E-03 | 9 | P51617, Q9UJU2, Q13546, Q13489, P10415, O60603, Q9BQS8, Q13561, P68371 | IRAK1, LEF1, RIPK1, BIRC3, BCL2, TLR2, FYCO1, DCTN2, TUBB2C | More | | Etacrynic-acid | hsa05133 | Pertussis | 1.70E-03 | 4 | P11215, P0DP23, P23528, P09871 | ITGAM, CALM1, CFL1, C1S | More | | Etacrynic-acid | hsa05152 | Tuberculosis | 2.95E-02 | 6 | P48382, O60603, P10415, P13765, Q9UDY8, P51617 | RFX5, TLR2, BCL2, HLA-DOB, MALT1, IRAK1 | More | | Etacrynic-acid | hsa05166 | Human T-cell leukemia virus 1 infection | 2.13E-02 | 5 | P01106, P09693, Q09472, P42773, P01730 | MYC, CD3G, EP300, CDKN2C, CD4 | More | | Etacrynic-acid | hsa05169 | Epstein-Barr virus infection | 1.36E-03 | 12 | P20023, P13765, P01106, Q13546, O00463, P10415, P24522, Q8WV28, O60603, P51617, Q14790, P09693 | CR2, HLA-DOB, MYC, RIPK1, TRAF5, BCL2, GADD45A, BLNK, TLR2, IRAK1, CASP8, CD3G | More | | Etacrynic-acid | hsa05170 | Human immunodeficiency virus 1 infection | 9.66E-03 | 9 | P17252, Q13546, O00463, Q14643, P51617, O60603, P09693, P10415, Q9Y6Q5 | PRKCA, RIPK1, TRAF5, ITPR1, IRAK1, TLR2, CD3G, BCL2, AP1M2 | More | | Etacrynic-acid | hsa05171 | Coronavirus disease - COVID-19 | 3.87E-04 | 5 | P62249, P40429, P27635, Q07020, P05386 | RPS16, RPL13A, RPL10, RPL18, RPLP1 | More | | Etacrynic-acid | hsa05203 | Viral carcinogenesis | 6.08E-03 | 4 | Q14790, Q09472, P62807, P33778 | CASP8, EP300, HIST1H2BC, H2BC3 | More | | Etacrynic-acid | hsa05204 | Chemical carcinogenesis | 5.00E-03 | 3 | P09211, P78417, P11712 | GSTP1, GSTO1, CYP2C9 | More | | Etacrynic-acid | hsa05213 | Endometrial cancer | 3.77E-02 | 2 | P01106, P24522 | MYC, GADD45A | More | | Etacrynic-acid | hsa05216 | Thyroid cancer | 1.68E-02 | 2 | P01106, P24522 | MYC, GADD45A | More | | Etacrynic-acid | hsa05322 | Systemic lupus erythematosus | 3.95E-02 | 2 | P62807, P33778 | HIST1H2BC, H2BC3 | More | | Etacrynic-acid | hsa05332 | Graft-versus-host disease | 3.49E-02 | 3 | P13765, P10747, P26715 | HLA-DOB, CD28, KLRC1 | More | | Etacrynic-acid | hsa05340 | Primary immunodeficiency | 4.61E-02 | 2 | P01730, P16871 | CD4, IL7R | More | | |